BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8665355)

  • 1. [Prevalence of hepatocellular carcinoma in cirrhotic patients with with portosystemic shunt. Cohort analysis].
    Elizalde JI; Castells A; Planas R; Rodríguez-Iglesias MP; Bruix J; Brú C; Saló J; Boix J; Gassull MA; Terés J; Rodés J
    Gastroenterol Hepatol; 1996 Apr; 19(4):189-93. PubMed ID: 8665355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful surgical treatment for hepatocellular carcinoma and concomitant risky esophageal varices.
    Yamamoto S; Sato Y; Takeishi T; Hirano K; Kobayashi T; Watanabe T; Hatakeyama K
    Hepatogastroenterology; 2005; 52(64):1083-6. PubMed ID: 16001634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Portosystemic shunts in the treatment of bleeding esophageal varices in cirrhotic patients: between sclerotherapy and transplantation].
    Gozzetti G; Cavallari A; Mazziotti A; Recordare A; Bellusci R; Nardo B; De Raffele E; Vivarelli M; Camillò B
    Minerva Chir; 1996 Nov; 51(11):887-95. PubMed ID: 9072715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.).
    Merli M; Salerno F; Riggio O; de Franchis R; Fiaccadori F; Meddi P; Primignani M; Pedretti G; Maggi A; Capocaccia L; Lovaria A; Ugolotti U; Salvatori F; Bezzi M; Rossi P
    Hepatology; 1998 Jan; 27(1):48-53. PubMed ID: 9425916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
    Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical approach to posthepatitic cirrhotic patient today].
    Meriggi F; Forni E
    G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the treatment of hepatocellular carcinoma and concomitant esophageal varices.
    Matsumata T; Kanematsu T; Shirabe K; Takenaka K; Kitano S; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):461-4. PubMed ID: 2174824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.
    Lo GH; Liang HL; Chen WC; Chen MH; Lai KH; Hsu PI; Lin CK; Chan HH; Pan HB
    Endoscopy; 2007 Aug; 39(8):679-85. PubMed ID: 17661241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatocellular carcinoma occurring after distal splenorenal shunt for esophagogastric varices.
    Hirano S; Kondo S; Omi M; Anbo Y; Katoh H
    Hepatogastroenterology; 2001; 48(40):1110-3. PubMed ID: 11490812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt--a comparative study.
    Khaitiyar JS; Luthra SK; Prasad N; Ratnakar N; Daruwala DK
    Hepatogastroenterology; 2000; 47(32):492-7. PubMed ID: 10791220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients.
    Meddi P; Merli M; Lionetti R; De Santis A; Valeriano V; Masini A; Rossi P; Salvatori F; Salerno F; de Franchis R; Capocaccia L; Riggio O
    Hepatology; 1999 Apr; 29(4):1074-7. PubMed ID: 10094949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection sclerotherapy for variceal bleeding in patients with irresectable hepatocellular carcinoma.
    Letier MH; Krige JE; Lemmer ER; Terblanche J
    Hepatogastroenterology; 2000; 47(36):1680-4. PubMed ID: 11149031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma.
    Yeh JL; Peng YC; Tung CF; Yang DY; Hu WH; Chow WK; Yeh HZ; Chen GH
    Hepatogastroenterology; 2003; 50(53):1603-8. PubMed ID: 14571795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-diameter H-graft portacaval shunt for variceal hemorrhage: experience at King Chulalongkorn Memorial Hospital.
    Sriussadaporn S; Pak-art R; Sriussadaporn S
    J Med Assoc Thai; 2004 Apr; 87(4):427-31. PubMed ID: 15217183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage.
    García-Villarreal L; Martínez-Lagares F; Sierra A; Guevara C; Marrero JM; Jiménez E; Monescillo A; Hernández-Cabrero T; Alonso JM; Fuentes R
    Hepatology; 1999 Jan; 29(1):27-32. PubMed ID: 9862845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Portasystemic shunt--our twenty years experience].
    Uravić M; Depolo A; Dobrila-Dintinjana R; Kraus I; Petrosić N; Stimać D; Bacić G
    Zentralbl Chir; 2002 Nov; 127(11):971-4. PubMed ID: 12476371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices.
    Nevens F; Broeckaert L; Rutgeerts P; Van Steenbergen W; Fevery J
    Hepatogastroenterology; 1995; 42(6):979-84. PubMed ID: 8847055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the long-term results of distal splenorenal shunt and esophageal transection for the treatment of esophageal varices.
    Tajiri T; Onda M; Yoshida H; Mamada Y; Taniai N; Yamashita K
    Hepatogastroenterology; 2000; 47(36):1619-21. PubMed ID: 11149016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Portosystemic shunts versus endoscopic therapy for esophageal varices after the first bleeding: does the Cochrane analysis give a complete answer?].
    Grønbaek H; Thomsen KL; Ott P; Vilstrup H
    Ugeskr Laeger; 2007 Aug; 169(34):2761-3. PubMed ID: 17878011
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.